Nordea Investment Management AB boosted its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 16.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,238,087 shares of the financial services provider's stock after buying an additional 608,224 shares during the period. Nordea Investment Management AB owned approximately 0.61% of MetLife worth $347,735,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in the company. Larson Financial Group LLC grew its stake in shares of MetLife by 72.6% in the 2nd quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider's stock worth $40,000 after buying an additional 239 shares in the last quarter. Private Advisor Group LLC boosted its holdings in shares of MetLife by 1.1% in the 2nd quarter. Private Advisor Group LLC now owns 94,696 shares of the financial services provider's stock worth $6,647,000 after purchasing an additional 1,046 shares during the period. Candriam S.C.A. raised its holdings in MetLife by 177.9% during the 2nd quarter. Candriam S.C.A. now owns 359,491 shares of the financial services provider's stock valued at $25,231,000 after buying an additional 230,116 shares during the period. Savant Capital LLC lifted its position in MetLife by 88.0% in the second quarter. Savant Capital LLC now owns 23,445 shares of the financial services provider's stock worth $1,646,000 after buying an additional 10,977 shares during the last quarter. Finally, Illinois Municipal Retirement Fund boosted its stake in MetLife by 614.8% during the second quarter. Illinois Municipal Retirement Fund now owns 146,073 shares of the financial services provider's stock worth $10,253,000 after buying an additional 125,637 shares during the period. Hedge funds and other institutional investors own 94.99% of the company's stock.
A number of equities analysts recently commented on MET shares. Barclays dropped their price target on shares of MetLife from $91.00 to $90.00 and set an "overweight" rating for the company in a research note on Thursday, October 31st. Piper Sandler increased their price target on MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a report on Wednesday, October 2nd. Jefferies Financial Group upped their price objective on MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a research report on Friday, September 27th. StockNews.com upgraded shares of MetLife from a "hold" rating to a "buy" rating in a report on Wednesday, January 1st. Finally, TD Cowen lifted their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a report on Wednesday, November 27th. Fourteen equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus target price of $88.62.
Get Our Latest Analysis on MET
NYSE MET opened at $82.21 on Monday. The firm has a market cap of $56.92 billion, a PE ratio of 16.57, a price-to-earnings-growth ratio of 0.76 and a beta of 1.07. MetLife, Inc. has a 52 week low of $64.61 and a 52 week high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a 50 day moving average price of $82.89 and a 200 day moving average price of $78.65.
The firm also recently announced a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Tuesday, November 5th were paid a dividend of $0.545 per share. The ex-dividend date of this dividend was Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.65%. MetLife's dividend payout ratio (DPR) is 43.95%.
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.